187 related articles for article (PubMed ID: 4028021)
1. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
[TBL] [Abstract][Full Text] [Related]
2. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
3. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
5. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
[TBL] [Abstract][Full Text] [Related]
6. c-myc amplification and expression in newly established human osteosarcoma cell lines.
Bogenmann E; Moghadam H; DeClerck YA; Mock A
Cancer Res; 1987 Jul; 47(14):3808-14. PubMed ID: 3297309
[TBL] [Abstract][Full Text] [Related]
7. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Huber BE; Dearfield KL; Williams JR; Heilman CA; Thorgeirsson SS
Cancer Res; 1985 Sep; 45(9):4322-9. PubMed ID: 2992777
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
10. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines.
Kozbor D; Croce CM
Cancer Res; 1984 Feb; 44(2):438-41. PubMed ID: 6692352
[TBL] [Abstract][Full Text] [Related]
12. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
13. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
[TBL] [Abstract][Full Text] [Related]
15. Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S.
Cherif D; Lavialle C; Modjtahedi N; Le Coniat M; Berger R; Brison O
Chromosoma; 1989 Jan; 97(4):327-33. PubMed ID: 2707103
[TBL] [Abstract][Full Text] [Related]
16. Amplification, expression and localization of the c-myc gene in BSp73 rat tumor cell lines.
Birnbaum M; Spiess E
Anticancer Res; 1988; 8(6):1185-91. PubMed ID: 2464334
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
18. myc family gene abnormality in lung cancers and its relation to xenotransplantability.
Gemma A; Nakajima T; Shiraishi M; Noguchi M; Gotoh M; Sekiya T; Niitani H; Shimosato Y
Cancer Res; 1988 Nov; 48(21):6025-8. PubMed ID: 3167852
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
[TBL] [Abstract][Full Text] [Related]
20. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
Galdemard C; Brison O; Lavialle C
Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
